[New post] Another Drug Shows Mortality Benefit for Severe COVID-19

zedie posted: " Pragmatic RECOVERY trial validates drug with prior "mixed results" Tocilizumab (Actemra) showed a slight but statistically significant mortality benefit in critically ill COVID-19 patients, according to a press release from the U.K.'s pr" Respond to this post by replying above this line New post on SOMEONE SOMEWHERE Another Drug Shows Mortality Benefit for Severe COVID-19 by zedie Pragmatic RECOVERY trial validates drug with prior "mixed results" Tocilizumab (Actemra) showed a slight but statistically significant mortality benefit in critically ill COVID-19 patients, according to a press release from the U.K.'s pragmatic RECOVERY trial. Of patients treated with tocilizumab, an IL-6 inhibitor used for rheumatoid arthritis and related conditions, 29% died within 28 days versus 33% […] Read more of this post This free site is ad-supported. Learn more ​ zedie | March 6, 2022 at 5:59 am | Tags: tocilizumab | Categories: MEDICINE, PHARMACOLOGY | URL: https://wp.me/pW0bq-ywy Comment    See all comments    Like Unsubscribe to no longer receive posts from SOMEONE SOMEWHERE. Change your email settings at Manage Subscriptions. Trouble clicking? Copy and paste this URL into your browser: https://zedie.wordpress.com/2022/03/06/another-drug-shows-mortality-benefit-for-severe-covid-19/ Thanks for flying with WordPress.com